As Osiris moves on from fraud­u­lent past, one ex­ec set­tles up with SEC

Two years af­ter the SEC charged four Osiris Ther­a­peu­tics ex­ecs for cook­ing the books to fab­ri­cate a rosy pic­ture at the com­pa­ny, fed­er­al reg­u­la­tors have hand­ed down their first judg­ment.

Bob­by Dwayne Mont­gomery, the for­mer chief busi­ness of­fi­cer at Osiris, has agreed to pay a civ­il penal­ty of $40,000 and be legal­ly barred from fu­ture vi­o­la­tions of se­cu­ri­ties laws, in­clud­ing those that pro­hib­it fal­si­fy­ing books and records and ly­ing to au­di­tors.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.